Document:

Exhibit 10.7

 

Execution Copy

 

EMPLOYMENT AGREEMENT

 

This
Employment Agreement (this “Agreement”) is made and entered into on this 15 day of February
2016, by and between Therapix Biosciences Ltd., a public company organized under the laws of the State of Israel
(the “Company”) and Elran Haber, Israeli I.D No. 040092702 residing at 23 Pinhas Eylon St., Holon, Israel
(the “Employee”. The Company and Employee shall be sometimes referred to each as a
“Party” and collectively as the “Parties”). 

 

		WHEREAS,	the Company desires to employ Employee on the terms and conditions set forth herein and Employee
desires to be employed by the Company and enter into this Agreement on such terms and conditions;

 

		WHEREAS	the Employee was formerly employed by the
                                                                                                                         Company as VP Business Strategy, according to the terms and provisions of that certain Employment Agreement between the
                                                                                                                         Company and Employee, dated March 1, 2014, as amended on August 24, 2014 (the "Initial Employment Agreement" 
                                                                                                                         and "Initial Employment"); 

 

		WHEREAS	as requested by Employee and
                                         unless hereby amended, Company agrees to undertake all obligations towards the Employee
                                         with respect to employment benefits provided during the Initial Employment, including,
                                         without limitation, rights for severance pay, Manager's Insurance Plan, Study Plan and
                                         other employment benefits. The Option Agreements executed between the Company and Employee
                                         in connection with the Initial Employment, which are attached hereto as Exhibit
                                         A1 and Exhibit A2, shall not be affected with the terms and conditions
                                         of this Agreements; and

 

		WHEREAS	the Parties hereby agree that in the event that
the employment of Employee in accordance with the terms hereunder is not approved by the applicable corporate and regulatory organs,
the Initial Employment Agreement shall revert into full force and effect;

 

NOW, THEREFORE, in consideration of the mutual
undertakings of the Parties, it is hereby agreed as follows:

 

		1.	duties and responsibilities

 

		1.1	Commencing as of November 1, 2015 (the “Effective Date”),
Employee shall be employed by the Company as a CEO (the “Position”) and shall perform such duties and activities
as are customarily performed by a CEO of a company and as shall be assigned to Employee from time to time by the Company's Board
of Directors. Employee shall report directly to the Company’s Board of Directors.

 

		1.2	Employee shall devote his working time and best efforts to the business
and affairs of the Company and the performance of Employee's duties hereunder, and shall not undertake or accept any other employment
or paid occupation. Notwithstanding the aforesaid, Employee shall be entitled to serve as a board member of other companies in
a manner that does not conflict or otherwise affect his employment hereunder.

 

		1.3	Employee shall be employed at the Company's facilities as shall be decided
by the Company’s Board. Employee acknowledges and agrees that the performance of Employee's duties may also require travel
outside of Israel, at the Company's request and expense. Such expense shall include flight tickets, accommodation, applicable mobile
phone expenses and reasonable out-of-pocket expenses in connection with such travel.

 

    

     

    

 

		1.4	Employee's liability towards the Company shall be that of an office holder
under the Companies Law-1999 and any other applicable law.

 

		2.	TERM AND TERMINATION

 

		2.1.	This Agreement and the employer-employee relationship created hereunder
shall enter into effect as of the Effective Date and shall remain in force and effect unless and until terminated as provided herein.

 

		2.2.	Either Party may terminate
this Agreement by providing the other Party with ninety (90) days prior written notice (the “Notice Period”).

 

		2.3.	Notwithstanding anything to the contrary herein, the Company may terminate
this Agreement and the employer-employee relationship hereunder at any time, and without derogating from any other remedy to which
the Company may be entitled, for Cause (as hereinafter defined), by providing Employee written notice thereof. In such event, this
Agreement and the employer-employee relationship hereunder shall be deemed effectively terminated as of the date of delivery of
such notice.

 

The term “Cause” shall
mean, but shall not be limited to: (i) a breach by Employee of any of the material terms or conditions of this Agreement, including
but not limited to Sections 4 and 5 below; or (ii) Employee's willful misconduct, or action of personal dishonesty, bad faith or
breach of trust towards the Company or any of its subsidiaries and/or affiliates; or (iii) the commission by Employee of a criminal
offense, or fraud against the Company and/or any of its subsidiaries and/or affiliates; or (iv) circumstances that deny Employee
to severance payment under any applicable law and/or under any judicial decision of a competent tribunal authority.

 

		2.4.	During the Notice Period, Employee shall continue working and shall cooperate
with the Company and use his best efforts to assist the integration of the person or persons who will assume Employee's responsibilities.

 

Notwithstanding,
the Company shall have the right, at any time during the Notice Period, to terminate the employment relationship immediately, in
which case the Company shall pay Employee the Salary due for the remaining period of the Notice Period, and the benefits set forth
in Section 3 below.

 

		2.5.	Upon the earlier of (a) the date of termination of the Notice Period; and
(b) the date of actual termination of employment for any reason other than for Cause (or in the event of termination for Cause
then immediately upon termination of employment), Employee shall return to the Company, at its principal office, any and all Company
equipment, property and documents in Employee's possession or control.

 

		2.6.	Any outstanding payment due by Employee to the Company in connection
with Employee's employment shall be repaid by Employee by the earlier of (a) the date of termination of the Notice Period or (b)
the date of actual termination of employment for any reason other than for Cause (or in the event of termination for Cause then
immediately upon termination of employment). Notwithstanding, the Company may set-off any such outstanding amounts due to it against
any payment due by the Company to Employee, subject to applicable law. 

 

		2.7.	The provisions of Sections 3.2.4 and 8.7 below and the provisions of the
Undertaking (as defined below), will remain in full force and effect after termination or expiration of this Agreement.

 

    2

     

    

 

		3.	Salary and benefits

 

In full consideration for Employee's
services hereunder, Employee shall be entitled to the following payments and benefits, effective as of the Effective Date:

 

		3.1	Salary

 

		3.1.1	The Employee shall be entitled to a gross monthly salary of NIS 45,000 (the
“Salary”).

 

		3.1.2	The Salary may be adjusted from time to time according to government directives
and other adjustments as may be required by applicable law.

 

		3.1.3	It is agreed between the Parties that the position that Employee holds within
the Company is a management position, which demands a special level of loyalty, and accordingly, the Work Hours and Rest Law (1951)
shall not apply to Employee's employment by the Company and this Agreement. Employee further acknowledges that the compensation
payable hereunder includes benefits that would otherwise not be due to Employee pursuant to applicable law.

 

		3.1.4	The Salary shall be payable monthly in arrears, in accordance with the Company's
usual practice, by the 9th day of the following calendar month.

 

		3.2	Manager's Insurance; Pension Fund

 

		3.2.1	The Company shall insure Employee under an accepted Manager's Insurance
Policy (the “Policy”), and shall pay an amount equal to (i) 8.33% of the Salary on account of severance pay
payable to Employee upon severance in accordance with the provisions of this Agreement; and (ii) 5% or 6% (as required under applicable
law and the General Approval referred to below) of the Salary towards pension fund payments, subject to the deduction of 5% of
the Salary to be paid towards the Policy on behalf of Employee. In addition, the Company shall pay an amount equal to up to 2.5%
of the Salary towards disability insurance in favor of Employee.

 

		3.2.2	Employee may extend an existing policy or plan and/or incorporate it into
the Policy, at Employee's discretion. In the event the Employee elects to be insured under a pension plan, the allocations set
forth in Section 3.2.1 above shall be adjusted in accordance with the pension plans policies', provided, however,
that in any event payments by the Company shall not exceed the amounts set forth in Section 3.2.1 above. In addition, all contributions
and amounts under this Section 3.2 shall not exceed tax exempt amounts pursuant to the Israeli Income Tax Ordinance and the regulations
thereunder, whereupon such amounts shall be decreased accordingly.

 

		3.2.3	During Employee's employment period with the Company, the Company shall
be the sole owner of the Policy. Other than as set forth below, in the event of a termination of this Agreement, the Company shall
transfer the title in and to the Policy to Employee.

 

		3.2.4	The Company and Employee agree and acknowledge that transfer of ownership of the severance
portion of the Policy to the Employee as set forth in Section 3.2.3 above shall be lieu and not in addition to any entitlement
of the Employee under any applicable law or this Agreement to severance pay, according to the General Approval of the Minister
of Labor and Welfare, regarding Employers’ Payments to Pension Funds and Insurance Policies in Lieu of Severance Pay
in Accordance with Section 14 of the Severance Pay Law 1963, attached hereto as Exhibit B (the “General
Approval”). Accordingly, the Company hereby waives any rights to said payments made to the Policy, except as set forth
in the General Approval.

 

    3

     

    

 

		3.3	Education Fund (Keren Hishtalmut)

 

The Company
shall pay an amount equal to 7.5% of the Salary to an Education Fund (Keren Hishtalmut) designated by the Employee (the
“Education Fund”), and shall deduct from the Salary an amount equal to 2.5% of the Salary on behalf
of Employee, and shall pay such amounts to the Education Fund. 

 

		3.4	Annual Recreation Allowance

 

Employee shall be
entitled to annual recreation allowance (Dmei Havra'a) according to applicable law.

 

		3.5	Vacation

 

Employee
shall be entitled to 20 paid vacation days (business days) per year (the “Vacation Days”) in
accordance with the Annual Vacation Law – 1951. Each leave shall be coordinated with the direct manager in advance, with
adequate regard to the needs of the Company.

 

The
Employee will make every effort to exercise his Vacation Days; provided however, if the Employee is unable to utilize all the Vacation
Days by the end of a calendar year, he shall be entitled to accumulate the unused balance of the Vacation Days standing to his
credit up to the maximum amount permitted by law. 

 

Subject
to applicable law, accrued vacation days shall not be redeemable by Employee until
and subject to termination of employment.

 

		3.6	Sick Leave

 

Employee
shall be entitled to paid sick leave pursuant to applicable law. Payments
by the Company of sick leave days in connection with disability payments shall be set-off against payments received by Employee
pursuant to Section 3.2 above.

 

		3.7	Expenses.

 

In
addition to the Salary, the Company shall reimburse Employee for travel expenses and petrol. The
Company shall also reimburse the Employee for reasonable out-of-pocket expenses, provided that such expenses were approved in advance
in writing by the Company. Reimbursement of the expenses hereunder shall be made against delivery by Employee to the Company of
tax receipts or other appropriate supporting documentation satisfactory to the Company.

 

		3.8	Mobile Phone

 

Employee
shall be entitled to NIS 300 (net) for each month for expenses related to mobile phone usage.

 

		3.9	Annual Bonuses.

 

At the end of each
calendar year, Employee shall be entitled to a bonus, of up to six Salaries, subject to the recognition of the Board of Directors
(the "Board") of the successful achievement of Company measureable objectives as shall be set forth in the Company's
annual work plan determined by the Board.

 

    4

     

    

 

		3.10	Options.

 

		3.10.1	Subject to and following (i) the sole discretion and approval of the Board,
the shareholders of the Company and any applicable Company organs, law or regulation, if and to the extent required (ii) the Company's
Compensation Policy then in effect, or as otherwise determined by the Company and approved by the Company's relevant organs, (iii)
the adoption of an Employee Share Option Plan (the "Plan") by the Board and its approval by the Israeli Tax Authorities
and the execution by Employee of an option agreement in a form approved by the Board, Employee shall be granted with an option
to purchase up to 700,000 Ordinary Shares of the Company, par value NIS 0.01 each, under the Plan (the “Option”).
The Option be subject to the provisions of the Plan, and shall vest over a 3 year period, on a quarterly basis. To the extent the
Employee's employment hereunder was terminated prior to an end of a quarter, Employee shall be entitled to the respective pro-rata
portion of the Option. Subject to the obtainment of all regulatory and corporate approvals, the exercise price of the Option shall
be in accordance with the provisions of Company's Compensation applicable to such determination of exercise price.

 

Notwithstanding
anything to the contrary in the Plan, the exercise term of the Option shall be 180 days following Employee's termination of engagement
with the Company. The Option shall be further subject to a cashless mechanism.

 

		3.10.2	The vesting schedule provided above shall be accelerated and any unvested
portion of the Option shall become fully vested and exercisable immediately prior to (i) a Change of Control Event (as defined
below), provided, however, that only 50% of the unvested portion of the Option shall become fully vested and exercisable; (ii)
termination by Employee of his employment by the Company due to Good Reason (as defined below); (iii) the consummation of an initial
public offering on an additional stock exchange or an uplisting; or (iv) termination by Company of Employee's employment hereunder
without Cause.

 

"Change
of Control Event" means (i) merger or consolidation with another entity where the voting securities of the company outstanding
immediately before the transaction constitute less than a majority of the voting power of the voting securities of the company
or the surviving entity outstanding immediately after the transaction; or (ii) the sale or disposition of all or substantially
all of the Company’s assets; which shall take place within 12 months as of Employee's appointment as the Company's CEO.

 

"Good Reason"
means (i) change in Employee's Position with the Company or its successor that materially reduces Employee's title, duties or level
of responsibility; or (ii) material change in the Company's business.

 

		3.10.3	The grant of the Option shall be subject to the obtainment by the Company
of all (i) applicable corporate approvals, including, without limitation, approvals by the Board and the shareholders of the Company;
and (ii) completion of appropriate filings with and obtainment of the required approvals of the Israeli Securities Authority, the
Tel Aviv Stock Exchange and the OTCQB, to the extent required.

 

		3.10.4	In case a regulatory approval (if indeed shall be required) is not obtained,
for reasons beyond the Company’s control, this shall not be considered to be a breach by the Company of this agreement, Employee
shall not hold any demand, allegations or claims against the Company in connection with the Company's failure to obtain such regulatory
approval.

 

		3.10.5	Nothing herein shall be construed as an obligation to grant any options
to the Employee.

 

    5

     

    

 

		3.11	Any and all benefit, right or payment to which Employee is entitled pursuant
to this Agreement shall be calculated based on the Salary only, excluding any additional compensation, payment or reimbursement
payable to Employee hereunder.

 

		3.12	Employee will bear any and all taxes applicable to Employee in connection
with amounts paid by Employee and/or the Company pursuant to this Section 3. The Company shall legally deduct and withhold income
tax payments and other obligatory payments, such as social security and mandatory health insurance, from all of the payments which
shall be paid to Employee hereunder and pursuant to applicable law, including all taxes imposed on any benefits granted to Employee
and on any part of the benefits which exceeds maximum exemption(s) provided by law.

 

		3.13	In the event that contributions or
amounts set forth hereinabove in connection with the social benefits shall exceed tax exempt amounts pursuant to the Israeli Income
Tax Ordinance and/or the regulations promulgated thereunder, then the Employee shall bear any and all taxes imposed thereupon.

 

		4.	CONFIDENTIALITY, proprietary RIGHTS AND NON-COMPETITION

 

Upon execution
hereof, Employee shall execute and deliver the Confidentiality, Proprietary Rights and Non-Competition Undertaking attached hereto
as Exhibit C (the “Undertaking”).

 

		5.	Employee
Representations and Warranties

 

Employee
hereby represents and warrants to the Company as follows: 

 

		5.1.	Employee has the necessary skills, knowledge,
ability, expertise and experience to fulfill his/her obligations hereunder, shall do so diligently, professionally and conscientiously
and shall comply with the regulations and procedures of the Company. 

 

		5.2.	The execution and delivery of this Agreement
and the fulfillment of the terms hereof will constitute the valid, binding and enforceable obligations of Employee and will not
violate, conflict with or constitute a default under or breach of any agreement and/or undertaking and/or instrument, judgment
or order to which the Employee is a party or by which he is bound, or any provision of law, rule or regulation applicable to the
Employee, and do not require the consent of any person or entity. In the performance of Employee's obligations hereunder, Employee
will not make use of (i) any confidential or proprietary information belonging to any third party, or (ii) any information to which
Employee is restricted from disclosing or using due to contractual undertakings or by law. 

 

		5.3.	Employee will not accept, whether during
the term of this Agreement or at any time thereafter, directly or indirectly, any payment, benefit and/or other consideration,
from any third party in connection with Employee's employment with the Company, without the Company's prior written authorization.

 

		5.4.	In the performance of Employee's duties
hereunder, Employee shall comply with all applicable laws and regulations, including, inter alia, the Company Internal Compliance
Plan (as defined below).

 

    6

     

    

 

		6.	Compensation
                                         Policy

 

		6.1.	Employee declares and confirms, that he
is familiar and aware that the Company has adopted a compensation policy pursuant to the provisions of the Companies Law 5759-1999
(the "Compensation Policy", and the "Law",
respectively), and that the terms of this Agreement are subject to and shall be aligned with the provisions and guidelines of the
Compensation Policy in force, unless otherwise determined from time to time by the Company and approved by the Company's relevant
organs. 

 

		6.2.	In the event that this Agreement and/or
any of its provisions shall be proclaimed and/or considered by a competent authority not aligned with the Compensation Policy and
not in accordance with the provision of the Law ("Conflicting Provision"),
then the parties shall cooperate to adjust any Conflicting Provision with the Compensation Policy or to approve such Conflicting
Provisions by the Company's relevant organs, in accordance with applicable law and regulations.

 

		6.3.	Without derogating from the Employee’s
rights under this Agreement, in the event that the abovementioned adjustment is not achievable, the Employee shall not have any
demand, allegations or claims against the Company.

 

		6.4.	Without derogating from the provisions
of the Compensation Policy, to the extent that any amount or fees paid to the Employee hereunder shall be revealed, within three
(3) years of the payment thereof, to have been paid based on erroneous calculations that have been restated in the Company's financial
statements, the Employee shall repay the Company amount paid in excess as aforesaid; all in accordance with the provisions of the
Compensation Policy.

 

		7.	Securities
                                         Internal Compliance Plan; Insider Trading Policy

 

Employee declares and
confirms, that he is familiar and aware that the Company has adopted a Securities Internal Compliance Plan (the "Internal
Compliance Plan"), and is familiar with its terms, obligations and restrictions, and shall act in accordance with the
provisions and guidelines of the Internal Compliance Plan in force, and as shall be determined from time to time.

 

		8.	Miscellaneous

 

		8.1.	The Company shall insure Employee under the Company's officers’ insurance
policy, in accordance with its terms.

 

		8.2.	Subject to the obtainment of all corporate and regulatory approvals, to the
extent required, Employee shall be entitled to exemption and indemnification in connection with the performance of his employment
hereunder, in accordance with the Exemption and Indemnification Letters in the forms previously approved by the Board.

 

		8.3.	This Agreement shall not invoke the provisions of any collective bargaining
agreement (Heskem Kibutsi), collective arrangement (Hesder Kibutzi), extension orders (Tzavei Harhava) or any other law, except
and only to the extent so mandated by law.

 

		8.4.	Preamble; Exhibits; Headings; Interpretation. The preamble to this
Agreement, and the Exhibits attached hereto, constitute an integral part hereof. Section headings contained herein are for reference
and convenience purposes only and shall not in any way be used for the interpretation of this Agreement.

 

		8.5.	Entire Agreement. The Parties confirm that this is a personal services
contract and that the relationship between them shall not be subject to any general or special collective employment agreement
or any custom or practice of the Company in respect of any of its other employees or contractors. This Agreement, together with
the Exhibits hereto, constitute the entire agreement between the parties with respect to the subject matters hereof and thereof
and supersede all prior agreements, understandings and arrangements, oral or written, between the parties with respect to the subject
matters hereof and thereof.

 

    7

     

    

 

		8.6.	Amendment; Waiver. Any term of this Agreement may be amended only
with the written consent of the Parties. The observance of any term hereof may be waived (either prospectively or retroactively
and either generally or in a particular instance) only with the written consent of the Party against which such waiver is sought.
No waiver by either Party at any time to act with respect to any breach or default by the other Party of, or compliance with, any
condition or provision of this Agreement to be performed by such other Party shall be deemed a waiver of similar or dissimilar
provisions or conditions at the same or at any prior or subsequent time.

 

		8.7.	Successors and Assign; Assignment. This Agreement shall be binding
upon and shall inure to the benefit of the Company, its successors and assigns. Neither this Agreement or any of the Employee's
rights, privileges, or obligations set forth in, arising under, or created by this Agreement may be assigned or transferred by
Employee without the prior consent in writing of the Company, except by will or by the laws of descent and distribution. The Company
may freely assign and/or transfer this Agreement and any of its rights, privileges, or obligations hereunder.

 

		8.8.	Governing Law; Jurisdiction. This Agreement shall be governed by and
construed and enforced in accordance with the laws of the State of Israel, without giving effect to the rules with respect to conflicts-of-law.
Any dispute arising out of, or relating to this Agreement, its interpretation or performance hereunder shall be resolved exclusively
by the competent court of the Tel Aviv-Jaffa district, and each of the parties hereby submits exclusively and irrevocably to the
jurisdiction of such court.

 

		8.9.	Severability. If any term or provision of this Agreement shall be
declared invalid, illegal or unenforceable, then such term or provision shall be enforceable to the extent that a court shall deem
it reasonable to enforce such term or provision and, if any such term or provision shall be held by any competent court to be unreasonable
to enforce to any extent, such term or provision shall be severed and all remaining terms and provisions shall be unaffected and
shall continue in full force and effect.

 

		8.10.	Notices. Each notice and/or demand given by a party pursuant to this
Agreement shall be in writing and sent by registered mail to the other party at the address appearing in the caption of this Agreement,
and such notice and/or demand shall be deemed given at the expiration of seven (7) days from the date of mailing by registered
mail or immediately if delivered by hand. Such address shall be effective unless notice of a change in address is provided by registered
mail to the other party.

 

		8.11.	The execution, delivery and performance of this Agreement is subject to the
obtainment of all applicable corporate and regulatory approvals, if and to the extent necessary.

 

[The
remainder of this page was intentionally left blank]

 

    8

     

    

 

[Signature Page
to Employment Agreement]

 

IN WITNESS WHEREOF, the parties have executed
this Employment Agreement as of the day and year first above written:

 

	/s/
    Therapix Biosciences Ltd.	 	/s/
Dr. Elran Haber
	Therapix
    Biosciences Ltd.	 	Dr.
    Elran Haber
	 	 	 	 
	By:	            	 	 
	 	 	 	 
	Title:
    	 	 	 

 

    

     

    

 

Exhibit
B

 

(unofficial
translation from Hebrew original)

 

A
General Approval regarding Employers' Payments to a Pension Fund and Insurance Fund in lieu of Severance Pay1

 

Pursuant
to the authority vested in me under Section 14 of the Severance Pay Law - 1963 (the "Law"), I hereby confirm that the
payments paid by an employer effective with publication date of publication of this approval for his employees to a comprehensive
pension in a provident fund that is not an insurance fund within the meaning of the Income Tax Regulations (rules on the approval
and management of provident funds) - 1964 (the "Pension Fund"), or to managers' insurance including the possibility
of an annuity or a combination of payments to annuity plan and to a plan that is not for a pension in such insurance fund (the
"Insurance Fund"), including payments paid through a combination of payments to a pension and Insurance Funds, whether
or not there is a pension plan in the Insurance Fund (the "Employer Payments"), will be in lieu of the severance pay
due to the employee in respect of the salary from which said payments were made and for the period payments were made (the “Exempt
Wage”) provided that all of the following were met:

 

	1.	Employer
                                         Payments

 

		a.	To
                                         a pension fund, payments that are not less than 14 1/3% of the Exempt Wage or 12% of
                                         the Exempt Wage if the employer pays for his employee payments in addition to supplement
                                         severance pay to the severance pay fund or to insurance fund in the name of employee
                                         at a rate of 2 1/3% of the Exempt Wage. If the employer does not pay in addition to 12%
                                         the 2 1/3% as above, the payments will be in lieu of only 72% of the employee's severance
                                         pay;

 

		b.	To
                                         an insurance fund, payments that are not less than one of the following:

 

		1)	13
                                         1/3% of the Exempt Wage if the employer pays for his employee also payments to secure
                                         monthly income in the event of work disability in a plan approved by the commissioner
                                         of capital market and insurance and savings in the Ministry of Finance at a rate required
                                         to secure at least 75% of the Exempt Wage or 2.5% of the Exempt Wage, whichever is lower
                                         ("Payment for Work Disability Insurance");

 

		2)	11%
                                         of the Exempt Wage if the employer paid insurance payments for work disability insurance
                                         and in this case the Employer Payments will be in lieu of 72% of the severance pay of
                                         the employee provided that; the employer paid in addition to these payments also payments
                                         for supplementing the severance pay severance to severance pay fund or to an insurance
                                         fund in the name of the employee at the rate of 2 1/3% of the Exempt Wage, the Employer
                                         Payments will be in lieu of 100% of the employee's severance pay.

 

	2.	Not
                                         later than three months after making the Employer Payments, a written agreement entered
                                         into between the employer and the employee containing the following –

 

	 	a)
    	the employee's consent
    to the arrangement according to this approval under the version specifying the payments of the employer and the pension fund
    and insurance fund, as the case may be; the agreement also shall include the version of this approval;
	 	 	 
	 	b)	a waiver of the
    employer in advance of any right it may have for a refund of monies from his payments unless the employee's right to severance
    pay was denied in a ruling under section 17 of the Law and to the extent such right was denied, or in the event that the employee
    withdrew money from the pension fund or the insurance fund not due to a qualifying event; In this regard, "qualifying
    event" - death, disability, or retirement at age of sixty or more.

 

	3.	This
                                         approval does not derogate from the employee's severance pay right under the Law, collective
                                         agreement, expansion order or labor agreement in respect of wages in excess of the Exempt
                                         Wage.

 

 

1
Law published 5758, 4394; 5760, 5; 5761, 1949.

 

     

     

    

 

EXHIBIT C

 

CONFIDENTIALITY,
proprietary
RIGHTS AND NON-COMPETITION UNDERTAKING

 

The following Undertaking confirms certain terms of
my employment with Therapix Biosciences Ltd. (for the purpose of this Undertaking, including its subsidiaries, parent companies
and/or affiliated entities, the “Company”), which is a material part of the consideration for my employment
by the Company and the compensation received by me from the Company from time to time. Capitalized terms not defined herein shall
have the meaning ascribed to them in the Employment Agreement to which this Undertaking is attached (the “Employment
Agreement”).

 

		1.	Confidentiality

 

		1.1.	I acknowledge that in the course of my employment with the Company I may (or may have) receive(d),
learn(ed), be(en) exposed to, obtain(ed), or have (had) access to non-public information relating to the Company, its business,
operations and activities, including without limitation any commercial, financial, business or technical information, inventions,
developments, processes, specifications, technology, know-how and trade secrets, information regarding marketing, operations, plans,
activities, customers, suppliers, business partners, subsidiaries, parent companies, affiliated entities etc. (“Confidential
Information”), and hereby undertake: (a) to maintain the Confidential Information in strict confidence at
all times and not to communicate, publish, reveal, describe, allow access to, divulge or otherwise disclose, expose or make available
the Confidential Information in whole or in part, to any person or entity, all whether directly or indirectly, and whether in writing
or otherwise; and (b) not to use the Confidential Information for any purpose other than for the performance of my
employment obligations. I further recognize that the Company may receive confidential or proprietary information from third parties,
subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited
purposes. Such information shall also be deemed “Confidential Information” hereunder, mutatis mutandis. 

 

		2.2.	In addition, I represent and warrant that I will keep the terms and conditions of the Employment
Agreement and this Undertaking strictly confidential and will not disclose it to any third person unless and to the extent required
by applicable law and subject to prior written notice to the Company.

 

		3.3.	Upon the earlier of the Company's request or the termination of my employment, I shall return to
the Company any and all documents and other tangible materials containing Confidential Information, and shall erase or destroy
any computer or data files in my possession containing Confidential Information, such that no copies or samples of Confidential
Information shall remain with me.

 

		4.4.	Without derogating from the above, all Confidential Information made available to, received by,
or generated by me shall remain the property of the Company (or its respective owners), and no license or other right in or to
the Confidential Information is granted hereby. Any and all material (including without limitation, files, records, documents,
design, drawings, specifications, equipment, notebooks, notes, memoranda, diagrams, blueprints, bulletins, formula, reports, analyses,
computer programs, software) and data of any kind relating to Confidential Information and/or Proprietary Rights (as defined below),
whether prepared by the undersigned or otherwise coming or having come into my possession, and whether or not marked or classified
as Confidential Information, shall remain the exclusive property of the Company (or its respective owners).

 

    EX-C-1

     

    

 

		2.	Proprietary
                                         Rights

 

		2.1.	I acknowledge and agree that any and all discoveries, inventions, ideas, developments, technology,
products, improvements, derivations, modifications, mask works, trade secrets, concepts, ideas, techniques, methods, processes
materials, proceeds, know-how, designs, works of authorship, and proprietary information, whether or not patentable or otherwise
protectable, invented, made, developed, discovered, conceived, conducted, reduced to practice, written, authored, compiled, produced
and/or created, in whole or in part, by me, independently or jointly with others, (i) during my employment with the Company;
or (ii) which result or arise from or relate to my employment with the Company, or work performed by or for the Company, or any
Confidential Information; or (iii) with the use of any Company equipment, supplies, facilities, trade secrets or proprietary information
of the Company; or (iv) which relate to the Company's business, technology or research and development, including any “Service
Inventions”, as defined in the Israeli Patent Law – 1967, (collectively, the “Inventions”), and
any and all right, title and interest in and to the Inventions, including without limitation, all patents, copyrights, trademarks,
trade names, moral rights and other intellectual, industrial and/or proprietary rights and applications, extensions and renewals
associated therewith (collectively and together with the Inventions, the “Proprietary Rights”), shall be the
sole and exclusive property of the Company its successors and assigns, as shall be designated by the Company. My aggregate compensation
terms in connection with my employment with the Company, include specific compensation for the assignment of such Proprietary Rights
to the Company and I shall have no title, rights, claims or interest whatsoever in or with respect to the Proprietary Rights and
specifically waive any right for additional compensation pursuant to Section 134 of the Israeli Patent Law - 1967. All works authored
by me pursuant to the Employment Agreement, including without limitation the Inventions, shall be deemed “work made for hire”.

 

		2.2.	I hereby irrevocably and unconditionally transfer and assign to the Company any and all of my rights,
title and interest, now and hereafter acquired, in and to the Proprietary Rights, (without any payments, liabilities or restrictions
to any person or third party) in any and all media now known or hereafter devised, and all claims and causes of action of any kind
with respect to any of the foregoing, throughout the world in perpetuity.

 

In the event that pursuant
to any applicable law I retain any rights in and to the Proprietary Rights that cannot be assigned to the Company, I hereby unconditionally
and irrevocably waive the enforcement of all such rights, and all claims and causes of action of any kind with respect to any of
the foregoing and agree, at the request and expense of the Company, to consent to and join in any action to enforce such rights
and to procure a waiver of such rights from the holders of such rights, if any.

 

In the event that I retain
any rights in and to Proprietary Rights that cannot be assigned to the Company and cannot be waived, I hereby grant the Company
an irrevocable, exclusive, perpetual, worldwide, royalty-free license to exploit, use, develop, perform, modify, change, reproduce,
publish and distribute, with the right to sublicense and assign such rights, and all claims and causes of action of any kind with
respect to any of the foregoing, in and to the Proprietary Rights, in any way the Company sees fit and for any purpose whatsoever.
Without derogating from the above, I hereby forever waive and agree never to assert any and all rights of paternity or integrity,
any right to claim authorship of any Invention, to object to any distortion, mutilation or other modification of, or other derogatory
action in relation to any Invention, and any similar right.

 

    EX-C-2

     

    

 

		2.3.	I will promptly disclose to the Company fully and in writing all Inventions but will otherwise
keep the Inventions in strict confidence in accordance with the provisions of Section 1 above.

 

		2.4.	I further agree and undertake to take all necessary measures and to fully cooperate with the Company,
during and after the term of my employment, in order to perfect, enforce, and/or defend the Proprietary Rights, and effectuate
the Company's title and interest therein, including without limitation as follows: (i) to keep accurate records relating
to the conception and reduction to practice of all Proprietary Rights, which records shall be the sole and exclusive property of
the Company and shall be surrendered to the possession of the Company, immediately upon their creation; and (ii) to
provide the Company with all information, documentation, and assistance, including the preparation or execution, as applicable,
of documents, declarations, assignments, drawings and other data, all such information, documentation, and assistance to be provided
at no additional expense to the Company, except for out-of-pocket expenses incurred by me at the Company's request or with the
Company's prior written consent. Without derogating from any of my obligations hereunder, I hereby appoint any officer of the Company
as my duly authorized agent to execute, file, prosecute and protect the same before any government agency, court or authority.

 

		3.	Non-Competition

 

		3.1.	I agree and declare that, so long as I am employed by the Company and for a period of six (6) months
thereafter, I will not, directly or indirectly, (i) engage in, participate, assist or become financially interested in,
any business venture worldwide that is engaged in any activity competing with or similar to the business or technology of the Company
as currently conducted and as proposed to be conducted from time to time; (ii) employ or otherwise engage, recruit or otherwise
solicit, induce or influence any person to leave the employment or service of the Company; and (iii) solicit or encourage
any customer, supplier or service provider to terminate or modify adversely its business relationship with the Company or otherwise
intervene in any relationship between the Company and any of its employees, contractors, suppliers or consultants.

 

		3.2.	I expressly acknowledge that the business objectives and targeted operating market of the Company
are worldwide, and consequently the obligations prescribed in this Section 3 shall apply on a worldwide basis.

 

For the purposes of this
Section 3, “directly or indirectly” includes doing business as an owner, partner, joint venturer, an independent
contractor, shareholder, director, officer, manager, broker, agent, employee, service provider or advisor, licensor or in any other
capacity whatsoever, but does not include holding up to 5% of the free market shares of any publicly traded companies.

 

		3.3.	I hereby acknowledge that the provisions of this Section 3 are reasonable to legitimately
protect Confidential Information, Proprietary Rights and Company property (including intellectual property and goodwill) to which
I, in my position in the Company, have been and will continue to be exposed, and that my compensation under the Employment Agreement
incorporates special consideration with respect for these non-competition undertaking.

 

		4.	General

 

		4.1.	The undersigned understands and agrees that monetary damages would not constitute a sufficient
remedy for any breach or default of the obligations contained in this Undertaking, and that the Company shall be entitled, without
derogating from any other remedies, to seek injunctive or other equitable relief to remedy or forestall any such breach or default
or threatened breach.

 

		4.2.	The provisions of the Employment Agreement relating to term and termination and the general provisions
thereof shall apply to this Undertaking, mutatis mutandis.

 

    EX-C-3

     

    

 

In
witness whereof, I hereby affix my name and signature, on this [__] day of __________, 2016.

 

	/s/
    Elran Haber	 
	Name: Elran Haber	 

 

    EX-C-4

     

    

 

1st Amendment Of Employment
Agreement

 

This
1st Amendment (the "Amendment") is made and entered into on
this 17 day of April, 2016, by and between Therapix Biosciences Ltd., a public company organized under the laws of the
State of Israel (the "Company"), and Dr.
Elran Haber, ID no. 040092702 (the “Employee”).
The Company and the Employee may be referred to collectively as the “Parties” and each as a “Party”.

 

		WHEREAS	the Company and the Employee
have entered into an Employment Agreement, dated February
15, 2016 (the "Agreement"); and

 

		WHEREAS	the Employee requested
to amend the Agreement as further set forth herein, and Company agreed to such amendment.

 

NOW
THEREFORE, in consideration of the mutual promises contained herein, and intending to be legally bound, the parties
hereby declare and agree as follows:

 

	1.	Capitalized terms used and not
otherwise defined herein shall bear the respective meanings ascribed to them in the Agreement.

 

	2.	Section 3.2.1 to the Agreement shall be deleted and replaced in its entirety with the following:

 

"The Company
shall insure Employee under an accepted Manager's Insurance Policy (the “Policy”), and shall pay the Employee
the following amounts: 

 

		(i)	The sum equal to 8.33% of the Salary on account of severance pay payable to Employee upon severance
in accordance with the provisions of this Agreement; and 

 

		(ii)	The sum equal to 5% or 6% of the Salary (the “Contributions Sum”), whereby
out of said Contributions Sums - an amount equals to 5% or 6% of the Exempted Income (as defined below) shall be paid towards Employee’s
pension fund (as required under applicable law and the General Approval referred to below) (the “Company’s Pension
Contributions Sum”), subject to the deduction of an amount equal to 5% or 5.5% of the said Exempted Income, to be paid
towards the Policy on behalf of and by the Employee (the “Employee’s Pension Contributions Sum”; and together
with the Company’s - the “Total Pension Contributions Sums”). 

 

The "Exempted
Income" shall mean the "ceiling amount" ("סכום התקרה")
as stated in Section (e3)(1) of the Income Tax Ordinance [New Version] 5721-1961, as shall be amended from time to time. 

 

For the avoidance
of doubt, it is clarified that the excess between the Contributions Sum and the Company’s Pension Contribution Sum, shall
be regarded part of the Employee’s Salary, in such manner, which reflects the fact that the over-all costs to the Company
('עלות מעביד כוללת') under this section is
not changed in any way simply for deducting Company’s Pension Contribution Sum from the Exempted Income rather than from
the Salary." 

 

		(iii)	In addition, the Company shall pay an amount equal to up to 2.5% of the Salary towards disability
insurance in favor of Employee.”

 

    

     

    

 

	3.	Section 5.5 shall be added to the Agreement, as follows:

 

"Without derogating
from the above, in the event that, notwithstanding the Employee's representations and undertakings hereunder, the Employee or anyone
on his behalf shall argue, or a court of competent jurisdiction shall determine, the existence of any right, remedy or lawful claim
against the Company with respect to the payment towards pension fund under Section 3.2.1(ii) (a “Claim”) , then
the following provisions shall apply: (i) the Employee's monthly Salary shall be considered to have been retroactively diminished
to the sum equal to 90% (ninety percent) of the sum of the Employee’s monthly Salary (the “Diminished Salary”);
and (ii) the Employee shall pay back the Company any sum or salary paid in excess within the period determined under said Claim
assuming Employee’s Salary was originally the Diminished Salary. The Company shall be entitled to set-off any amount due
to it pursuant to this Section 5.5 from any amount due to Employee pursuant to this Agreement."

 

	4.	Employee represents and warrants to the Company that (a) this Amendment is made at Employee's own
will and at his request; (b) Employee was advised by the Company to consult with legal and all other relevant advisors with respect
to this Amendment, and he understands the entire meaning and scope of implications of this Amendment, including without derogating
the generality of the aforesaid, any implications on Employee’s accumulated pension funds under the Policy.

 

	5.	The Agreement, as amended hereby, shall continue in full force and effect as originally constituted
and is hereby ratified and affirmed by the Parties. Any contradiction in meaning and/or interpretation between the Agreement and
this Amendment shall have the meaning and/or be interpreted in light of this Amendment.

 

[Signature Page to Follow]

 

    

     

    

 

IN WITNESS WHEREOF, the parties have duly executed
this Amendment as of the date first written above.

 

	/s/
    Dr. Elran Haber	 	/s/
    Therapix Biosciences Ltd.
	Dr.
    Elran Haber	 	Therapix
    Biosciences Ltd.
	 	 	 	 
	 	 	By:	             
	 	 	 	 
	 	 	Title:Exhibit
10.8

 

Execution
Copy

 

CONSULTING
AGREEMENT

 

THIS
CONSULTING AGREEMENT (this "Agreement") is made as of this 29 day of November (the "Effective Date"),
by and between Therapix Biosciences Ltd., a company organized under the laws of the State of Israel (the "Company")
with registered address at Azrieli Center, 27th floor, Tel-Aviv 67025, Israel, and Doron Ben-Ami ,ID no. 57690653 (the
"Consultant"). The Company and the Consultant shall sometimes be referred to, each as a "Party"
and collectively, as the "Parties".

 

	WHEREAS,	the Company desires to engage the Consultant as its
Chief Strategy Officer and the Consultant desires to serve the Company in such position, on the terms and conditions hereinafter
set forth.

 

NOW,
THEREFORE, based on the representations contained herein and in consideration of the mutual promises and covenants set forth
herein, the Parties agree as follows:

 

	1.	Services

 

		1.1.	Commencing
                                         as of the Effective Date, the Consultant will perform such services and will have such
                                         duties, authorities and responsibilities as are consistent with the position of Chief
                                         Strategy Officer, reporting directly to the CEO. Such services, together with any other
                                         services and tasks assigned to the Consultant from time to time and agreed upon with
                                         the Consultant in advance, shall be referred to herein as the "Services".

 

		1.2.	Consultant
                                         shall devote his attention, know-how, energy, talent, experience and best efforts to
                                         the performance of the Services under this Agreement and the business and affairs of
                                         the Company. Consultant shall be engaged in the position of Chief Strategy Officer on
                                         a part-time basis, such that Consultant shall devote 20% (Twenty percent) of his working
                                         time to the business and affairs of the Company and the performance of his duties and
                                         obligations hereunder.

 

		1.3.	Consultant
                                         shall be available from time to time for consultations by telephone and email, for weekly
                                         teleconferences with the Company and/or meetings with third parties as shall be required
                                         by the Company and coordinated in advance with Consultant.

 

		1.4.	The
                                         Parties agree that Consultant shall be an independent contractor of the Company and in
                                         no event shall an employer-employee or principal-agent relationship be established between
                                         the Company and Consultant. Consultant acknowledges and undertakes that it shall not
                                         represent itself as an agent of the Company, except to the extent expressly authorized
                                         by the Company's Board of Directors (the "Board").

 

		1.5.	The
                                         Parties agree that the execution and delivery of this Agreement and any provision hereof
                                         shall be subject to the approval of the Company's relevant corporate organs and all applicable
                                         laws and regulations, including, without limitation, approvals of the Israeli Securities
                                         Authority and the Tel Aviv Stock Exchange Ltd., (and the OTCQB, if required), and nothing
                                         herein shall be construed deemed a breach of this Agreement in the event that such required
                                         approval is not obtained.

 

    	 		 

     

    

 

	2.	Representations
                                         and Warranties

 

		2.1.	Consultant
                                         hereby represents, warrants and covenants to the Company, and acknowledges that the Company
                                         is entering into this Agreement in reliance thereon, as follows:

 

		2.2.	Consultant
                                         has the necessary skills, knowledge and experience to fulfill Consultant’s obligations
                                         hereunder, shall do so diligently, professionally and conscientiously and shall use Consultant’s
                                         best efforts in the performance thereof.

 

		2.3.	The
                                         execution and delivery of this Agreement and the fulfillment of the terms hereof will
                                         constitute the valid, binding and enforceable obligations of Consultant and will not
                                         violate, conflict with or constitute a default under or breach of any agreement and/or
                                         undertaking and/or instrument, judgment, order, writ or decree to which Consultant is
                                         a party or by which he is bound, or any provision of law, rule or regulation applicable
                                         to Consultant, including without limitation, any confidentiality or non competition agreement,
                                         and do not require the consent of any person or entity. In the performance of Consultant’s
                                         obligations hereunder, Consultant will not make use of (i) any confidential or proprietary
                                         information belonging to any third party, or (ii) any information which Consultant is
                                         restricted from disclosing or using due to contractual undertakings or by law.

 

		2.4.	In
                                         the performance of Consultant’s duties hereunder, Consultant shall comply with
                                         all applicable laws and regulations, including, without limitation, the Company Internal
                                         Compliance Plan (as defined below).

 

		2.5.	Consultant
                                         will refrain from engaging in any business or other activity which may be of conflict
                                         of interest with Consultant’s duties and obligations hereunder, and shall promptly
                                         notify the Company of any such matter or activity.

 

	3.	Compensation
                                         

 

As
full consideration for the Services during the Term on this Agreement (as defined below), the Consultant shall be entitled to
the following:

 

		3.1.	Within
                                         7 days following the end of the first calendar month during which the Services hereunder
                                         are provided, Consultant shall notify the Company of his election to receive a Monthly
                                         Fee or Accrued Fee (as both are defined below). The applicable provisions shall apply
                                         accordingly:

 

		3.1.1.	Monthly
                                         Fee.

 

Commencing
as of the Effective Date, the Company shall pay the Consultant a monthly retainer consulting fee of NIS 8,000 in consideration
for Services, plus V.A.T (the "Monthly Fee").

 

The
Monthly Fee shall be payable within ten (10) days following the end of each calendar month, against the submission at the beginning
of each month to the Company of a valid invoice in relation to the preceding month. A Tax Invoice will be issued following actual
payment transfer of the Monthly Fee, to be wired into an account to be designated by the Consultant and advised in writing to
the Company.

 

    	 	1	 

     

    

 

		3.1.2.	Accrued
                                         Fee. 

 

		a.	In
                                         case the Consultant elects not to receive the Monthly Fee, the Consultant shall be entitled
                                         to an accrued fee equal to the monthly retainer consulting fee of NIS 8,000 in plus VAT,
                                         accumulated during the Term (as such is defined below) (the "Accrued Fee").

 

Unless
converted into equity in accordance with Section 3.1.2(b) below, the Accrued Fee shall be payable within thirty (30) days following
the date of termination or expiration of this Agreement, against the submission by the Consultant to the Company of a valid invoice
in relation to the preceding month. A Tax Invoice will be issued following actual payment transfer of the Accrued Fee, to be wired
into an account to be designated by the Consultant and advised in writing to the Company.

 

		b.	Within
                                         5 (five) days following the termination or expiration of this Agreement, Consultant shall
                                         notify in writing to the Company if he desires to convert the Accrued Fee to Ordinary
                                         Shares of the Company, par value NIS 0.01 (the "Ordinary Shares" and
                                         collectively, the "Conversion"), in lieu of payment of the Accrued Fee.
                                         The Conversion shall be calculated based on the average closing price per Ordinary Share
                                         during the preceding 30 trading days prior to Consultant's election date with respect
                                         to such Conversion. If Consultant shall not notify the Company in the abovementioned
                                         manner, the Company shall elect, in its sole discretion, by which specific method as
                                         described in this sub section to pay the Consultant the Accrued Fee.

 

		c.	The
                                         Conversion shall be subject to the obtainment by the Company of all (i) applicable corporate
                                         approvals, including, without limitation, approvals by the Board and the shareholders
                                         of the Company; and (ii) completion of appropriate filings with and obtainment of the
                                         required approvals of the Israeli Securities Authority and/or the Tel Aviv Stock Exchange
                                         Ltd., (and the OTCQB, if required).

 

In
case Consultant elects the Conversion method, yet a regulatory approval (if indeed shall be required) is not obtained, for reasons
beyond the Company’s control, this shall not be considered to be a breach by the Company of this agreement, Consultant shall
not hold any demand, allegations or claims against the Company, in such event and the Parties shall cooperate in good faith to
achieve any other agreed arrangement they deem suitable in this matter.

 

Nothing
herein shall be construed as an obligation to grant the Consultant of any Ordinary Shares underlying the Conversion.

 

    	 	2	 

     

    

 

		d.	In
                                         the event that any applicable approval according to sub-section c above is not obtained
                                         within 45 (forty five) days following Consultant's notification to the Company of his
                                         election to convert according to sub-section b above, then the Company shall pay the
                                         Consultant the Accrued Fee, and the Conversion shall become null and void.

 

		e.	In
                                         any case, and for demonstrational and regulatory purposes only, such Conversion shall
                                         not entitle the Consultant for more than 1,713,357 Ordinary Shares (which as of November
                                         29, 2015 share trading price demonstrates an accrued fees of NIS 1,559,155 (approximately
                                         155,156 monthly fees), and which shares reflect 4.99% of the issued and outstanding share
                                         capital of the Company as of the Effective Date). Nothing herein shall be construed as
                                         an obligation by the Company to engage with the Consultant for said period (or any part
                                         thereof), and the abovementioned calculations are to be used for demonstrational and
                                         regulatory purposes only, and in any event shall not derogate from the provisions of
                                         section 10 [Term and Termination] to this Agreement.

 

		3.1.3.	Option.
                                         

 

		a.	Subject
                                         to and upon the later of (i) the sole discretion and approval of the Board, the shareholders
                                         of the Company and any applicable Company organs, law or regulation, to the extent applicable
                                         (ii) the Company's Compensation Policy then in effect, (iii) the adoption of an Employee
                                         Share Option Plan (the "Plan") by the Board and its approval by the
                                         Israeli Tax Authorities, and (iv) the execution by Consultant of a standard option agreement
                                         in a form approved by the Board, Consultant shall be granted with an option to purchase
                                         up to 100,000 Ordinary Shares of the Company, par value NIS 0.01, each under the Plan
                                         (the "Shares" and collectively, the “Option”). The
                                         Option shall be subject to the provisions of the Plan and shall vest over a 3 year period,
                                         on a quarterly basis.

 

		b.	The
                                         grant of the Option shall be subject to the obtainment by the Company of all (i) applicable
                                         corporate approvals, including, without limitation, approvals by the Board and the shareholders
                                         of the Company; and (ii) completion of appropriate filings with and obtainment of the
                                         required approvals of the Israeli Securities Authority and/or the Tel Aviv Stock Exchange
                                         (and the OTCQB, if required).

 

		c.	In
                                         case a regulatory approval (if indeed shall be required) is not obtained, for reasons
                                         beyond the Company’s control, this shall not be considered to be a breach by the
                                         Company of this agreement, Consultant shall not hold any demand, allegations or claims
                                         against the Company in connection with the Company's failure to obtain such regulatory
                                         approval.

 

		d.	Nothing
                                         herein shall be construed as an obligation to grant any options to the Consultant.

 

    	 	3	 

     

    

 

		3.2.	Expenses.
                                         Without derogating from the above, the Company shall reimburse the Consultant for all
                                         out-off pocket expenses reasonably required in the performance of the Services by the
                                         Consultant under this Agreement and approved in advance by the Company. Reimbursement
                                         shall be made against delivery by Consultant to the Company of tax receipts or other
                                         appropriate supporting documentation satisfactory to the Company. Such expenses shall
                                         include travel expenses, which shall be made at business class rates, using Company's
                                         travel agent and most favorable rates, and subject to prior written approval.

 

		3.3.	Consultant
                                         shall be solely responsible to pay all taxes, levies, social benefits, insurance payments
                                         and any other payments required by law due in connection with this Agreement, whether
                                         in Israel or abroad, provided, however, that the Company
                                         may withhold all amounts as required by applicable law from payments hereunder or in
                                         connection with this Agreement.

 

		3.4.	Consultant
                                         shall be not entitled to receive any other right, compensation or payment from the Company,
                                         other than as expressly stated in this Section 3.

 

		3.5.	The
                                         Company shall insure Mr. Doron Ben-Ami under the Company's officers’ insurance
                                         policy, in accordance with its terms.

 

	4.	Proprietary
                                         Rights 

 

		4.1.	The
                                         Consultant agrees and declares that any and all products, improvements, derivations,
                                         materials, processes, techniques, know-how and/or proceeds and any and all inventions,
                                         ideas, discoveries, concepts, works of authorship, designs, data results or initiatives
                                         conceived, conducted, developed, reduced to practice, compiled, created, written, authored,
                                         made and/or produced by the Consultant, alone or jointly with others, pursuant to, in
                                         connection with, resulting or arising from this Agreement and/or the provision of the
                                         Services to the Company, or trade secrets of the Company, whether within the scope of
                                         the provision of the Services hereunder to the Company or otherwise and whether during
                                         the Term of this Agreement, prior thereto or thereafter, directly or indirectly related
                                         to the technology of the Company as currently conducted and/or proposed to be conducted
                                         (the "Inventions") and any and all right, title and interest in and
                                         to the Inventions, including without limitation, all patents, copyrights, trademarks,
                                         trade names, moral rights and other intellectual, industrial and/or proprietary rights
                                         and applications, extensions and renewals thereof (together with the Inventions, the
                                         "Proprietary Rights"), shall be the sole and exclusive property of the
                                         Company, its successors and assigns (for the purpose of this Section 4, collectively,
                                         the "Company"), and that the Consultant will not have any rights or
                                         title whatsoever thereto, including, although not an employee, any right to receive compensation
                                         pursuant to Section 134 of the Israeli Patent Law - 1967. All works authored by the Consultant
                                         pursuant to this Agreement, including, without limitation, the Inventions, shall be deemed
                                         "works made for hire".

 

    	 	4	 

     

    

 

		4.2.	If
                                         and to the extent the Company’s sole and exclusive ownership of the Proprietary
                                         Rights, in whole or in part, is not recognizable for any reason whatsoever, the Consultant
                                         hereby irrevocably transfers and assigns to the Company, solely and exclusively, all
                                         its/his rights, title and interest now and hereafter acquired in and to all Proprietary
                                         Rights (without any payments, liabilities or restrictions to any person or third party)
                                         in any and all media now known or hereafter devised, and all claims and causes of action
                                         of any kind with respect to any of the foregoing, throughout the world in perpetuity,
                                         and, when not otherwise assignable herein, agrees and undertakes to assign in the future
                                         to the Company all right, title and interest in and to any and all such Proprietary Rights
                                         (and all proprietary rights with respect thereto) and further undertakes to execute all
                                         necessary documentation and take all further action as may be required in order to perform
                                         such assignment, at the Company’s expense.

 

		4.3.	In
                                         the event that pursuant to any applicable law the Consultant retains any rights in and
                                         to the Proprietary Rights that cannot be assigned to the Company, the Consultant hereby
                                         unconditionally and irrevocably waives the enforcement of all such rights, and all claims
                                         and causes of action of any kind with respect to any of the foregoing and agrees, at
                                         the request and expense of the Company, to consent to and join in any action to enforce
                                         such rights and to procure a waiver of such rights from the holders of such rights, if
                                         any.

 

		4.4.	In
                                         the event that the Consultant retains any rights in and to Proprietary Rights that cannot
                                         be assigned to the Company and cannot be waived, the Consultant hereby grants the Company
                                         an exclusive, perpetual, worldwide, royalty-free license to exploit, use, develop, perform,
                                         modify, change, reproduce, publish and distribute, with the right to sublicense and assign
                                         such rights, and all claims and causes of action of any kind with respect to any of the
                                         foregoing, in and to the Proprietary Rights, in any way the Company sees fit and for
                                         any purpose whatsoever. Without derogating from the above, the Consultant hereby forever
                                         waives and agrees never to assert any and all rights of paternity or integrity, any right
                                         to claim authorship of any Invention, to object to any distortion, mutilation or other
                                         modification of, or other derogatory action in relation to any Invention, whether or
                                         not such would be prejudicial to his honor or reputation, and any similar right, existing
                                         under judicial or statutory law of any country in the world, or under any treaty, even
                                         after termination of its/his work on behalf of the Company.

 

		4.5.	Without
                                         derogating from the above, any and all material (including, without limitation, software,
                                         designs, documentation, memoranda, notes, reports, manuals, patterns, programs, specifications,
                                         prototypes, formulas, drawings, records, data or other technical or proprietary information),
                                         and any copies or abstracts thereof, whether or not of a secret or confidential nature,
                                         furnished to the Consultant by the Company or conceived, conducted, developed, reduced
                                         to practice, compiled, created, written, authored, made and/or produced by the Consultant,
                                         alone or jointly with others, pursuant to, in connection with, resulting or arising from
                                         this Agreement and/or the provision of Services to the Company, or trade secrets of the
                                         Company, whether within the scope of the consultancy with the Company or otherwise and
                                         whether during the Term of this Agreement, prior thereto or thereafter, directly or indirectly
                                         related to the business of the Company as currently conducted and/or proposed to be conducted,
                                         is and shall remain the sole and exclusive property of the Company. Such property while
                                         in the Consultant’s custody or control, as applicable, shall be maintained in good
                                         condition at Consultant’s expense, as applicable.

 

    	 	5	 

     

    

 

		4.6.	The
                                         Consultant will promptly disclose to the Company fully and in writing (but otherwise
                                         keep in confidence) all Inventions. All inventions and proprietary rights owned by the
                                         Consultant prior to the Effective Date are set forth in Exhibit A hereto,
                                         and shall remain the sole and exclusive property of the Consultant. Consultant hereby
                                         agrees and undertakes to provide the Company or any person designated by the Company
                                         all such information, to execute all necessary documentation and to take all further
                                         action as may be required to perfect the rights referred to herein, including, without
                                         limitation, any assignment of rights to the Company or the obtaining or enforcing any
                                         intellectual property rights, if applicable, in any and all countries, provided, that
                                         the Company will compensate the Consultant at a reasonable rate for time or expenses
                                         actually spent by him at the Company’s request on such assistance. Without derogating
                                         from any of the Consultant’s obligations hereunder, the Consultant hereby appoints
                                         any officer of the Company as its duly authorized agent to execute, file, prosecute and
                                         protect the same before any government agency, court or authority.

 

		4.7.	Consultant’s
                                         undertakings in this Section ‎4 shall remain in full force and effect after termination
                                         or expiration of this Agreement for any reason whatsoever or any renewal thereof.

 

	5.	Confidentiality
                                         

 

		5.1.	Consultant
                                         represents and warrants that it will keep the terms and conditions of this Agreement
                                         strictly confidential and will not disclose it or provide a copy of this Agreement or
                                         any part thereof to any third person unless and to the extent required by applicable
                                         law and except for his counsels Advisors and first degree family member, and only on
                                         a need to know basis.

 

		5.2.	Any
                                         and all information and data of a proprietary or confidential nature concerning the business
                                         or financial activities of the Company or its technology or products (whether current
                                         or future), whether in oral, written, graphic, machine-readable form, or in any other
                                         form, including, without limitation, proprietary, business, financial, technical, development,
                                         product, marketing, sales, price, operating, performance, cost, know-how and process
                                         information, trade secrets, patents, patent applications, copyrights, ideas and inventions
                                         (whether patentable or not), and all record bearing media containing or disclosing such
                                         information and techniques, disclosed to or otherwise acquired by the Consultant in connection
                                         with this Agreement and any and all Proprietary Rights (collectively, "Confidential
                                         Information") is and shall remain the sole and exclusive property of the Company.

 

		5.3.	At
                                         all times, both during the term of this Agreement and thereafter, the Consultant: (i)
                                         will keep the Confidential Information strictly confidential and will not disclose it,
                                         or any part thereof, provide any documentation with respect thereto, or any part thereof,
                                         directly or indirectly, to any third party, without the prior written consent of the
                                         Company or unless and to the extent required by applicable law; and (ii) will not use
                                         any Confidential Information or anything relating to it without the prior written consent
                                         of the Company, except and to the extent as may be necessary in the ordinary course of
                                         performing its/his duties and obligations hereunder and in the best interests of the
                                         Company. Notwithstanding the foregoing, the Consultant shall not be obligated to maintain
                                         the confidentiality of the Confidential Information which: (i) is or becomes a matter
                                         of public knowledge through no fault of the Consultant, or breach of this Agreement;
                                         (ii) is authorized, in writing, by the Company for release; (iii) was lawfully in the
                                         Consultant’s possession before receipt from the Company, as evidenced by the Consultant,
                                         as the case may be, through written documentation; (iv) is lawfully received by the Consultant
                                         from a third party without a duty of confidentiality; or (v) reflects information and
                                         data generally known within the industries or trades in which the Company transacts business
                                         or (vi) is required to be revealed by a competent authority's decision.

 

    	 	6	 

     

    

 

		5.4.	At
                                         all times, both during the term of this Agreement and thereafter Consultant will keep
                                         in trust all Confidential Information. In the event of the termination of this Agreement
                                         for any reason, or upon the Company’s earlier request, the each of the Consultant
                                         will promptly deliver to the Company all materials referred to herein and the Consultant
                                         shall not retain or take any materials, or any reproduction thereof containing or pertaining
                                         to Confidential Information.

 

		5.5.	The
                                         Consultant recognizes that the Company received and will receive confidential or proprietary
                                         information from third parties, subject to a duty on the Company’s part to maintain
                                         the confidentiality of such information and to use it only for certain limited purposes.
                                         At all times, both during the Term of this Agreement and after its termination, the Consultant
                                         undertakes to keep any and all such information in strict confidence and trust, and it
                                         will not use or disclose any of such information without the prior written consent of
                                         the Company, except as may be necessary to perform his duties hereunder and consistent
                                         with the Company’s agreement with such third party. Upon termination of this Agreement,
                                         the Consultant shall act with respect to such information as set forth in Section 5.4.

 

	6.	Indemnification

 

		6.1.	The
                                         Consultant is an independent contractor and it and its employees and consultants do not
                                         and shall not represent themselves to be the agents, employees, partners or joint venturers
                                         of the Company. Nothing in this Agreement shall be interpreted or construed as creating
                                         or establishing any partnership, joint venture, employment relationship, franchise or
                                         agency or any other similar relationship between the Company and the Consultant or any
                                         of its employees and consultants and neither party shall be held liable for the debts
                                         or obligations of the other.

 

		6.2.	The
                                         Consultant hereby undertakes to indemnify and reimburse the Company for any amounts claimed
                                         or levied on the Company (including related costs and expenses) due to taxes, social
                                         insurance payments, pension payments, health insurance and any other such payments resulting
                                         from any payment made by the Company to the Consultant under this Agreement, whether
                                         in connection to Consultant.

 

		6.3.	Without
                                         derogating from the above, in the event that, notwithstanding the Parties’ representations
                                         and undertakings hereunder, the Consultant or anyone on its behalf, shall claim, or a
                                         court of competent jurisdiction shall determine, the existence of employer-employee relationship
                                         between the Consultant and the Company, then the following provisions shall apply: (i)
                                         the Consultant's monthly salary for such claimed or determined period of employer-employee
                                         relationship shall be equal to 70% (seventy percent) of the sum of the Monthly Fee and
                                         expenses reimbursement due to the Consultant as consideration for the Services rendered
                                         hereunder (for the purposes of this Section ‎6.3, the "Monthly Salary");
                                         and (ii) the Monthly Salary shall be deemed to constitute all of the Company’s
                                         liabilities and obligations towards the Consultant, of any source or origin, with respect
                                         to and in connection with said employer-employee relationship, except for such rights
                                         with respect to which global compensation may not be determined pursuant to applicable
                                         law. The Company shall be entitled to set-off any amount due to it pursuant to this Section
                                         ‎6.3 from any amount due to Consultant pursuant to this Agreement.

 

    	 	7	 

     

    

 

	7.	Non
                                         Competition; Non Solicitation

 

		7.1.	Consultant,
                                         agrees and undertakes that he will not, during the Term of this Agreement and for a period
                                         of one (1) year thereafter, compete or assist others to compete, whether directly or
                                         indirectly, with the business of the Company, as currently conducted and/or proposed
                                         to be conducted.

 

		7.2.	Consultant
                                         agrees and undertakes that during the Term of this Agreement and for a period of one
                                         (1) year thereafter, it/she will neither solicit for employment or any other engagement
                                         nor employ or otherwise engage any person employed by the Company on the date of such
                                         termination or during the preceding twelve (12) months, personally or in any business
                                         in which he is an officer or director, for any purpose or in any place, provided that
                                         the foregoing restriction shall not apply to employment or engagement of an employee:
                                         (i) following an employee’s affirmative response to a general recruitment effort
                                         carried out through a public solicitation or general solicitation, or (ii) upon an employee’s
                                         initiative.

 

		7.3.	If
                                         any one or more of the terms contained in Sections ‎7.1 and ‎7.2 shall, for any
                                         reason, be held to be excessively broad with regard to time, geographic scope or activity,
                                         such term shall be construed in a manner to enable it to be enforced to the extent compatible
                                         with applicable law.

 

	8.	Compensation
                                         Policy

 

		8.1.	Consultant
                                         declares and confirms, that he is familiar and aware that the Company has adopted a compensation
                                         policy pursuant to the provisions of the Companies Law 5759-1999 (the "Compensation
                                         Policy", and the "Law", respectively), and that the terms of
                                         this Agreement are subject to and shall be aligned with the provisions and guidelines
                                         of the Compensation Policy in force, and as shall be determined from time to time. Copy
                                         of the Compensation Policy is attached hereto as an integral part of this Agreement.

 

		8.2.	In
                                         the event that this Agreement and/or any of its provisions shall be proclaimed and/or
                                         considered by a competent authority not aligned with the Compensation Policy and not
                                         in accordance with the provision of the Law ("Contradicting Term"),
                                         then the Parties shall cooperate to adjust any Contradicting Term with the Compensation
                                         Policy or to be approved by the Company’s relevant organs, as per the Parties consent
                                         and in accordance with applicable law and regulations.

 

		8.3.	Without
                                         derogating from the Consultant’s rights under this Agreement, in the event that
                                         the abovementioned adjustment is not possible or achievable under the circumstances,
                                         Consultant shall not hold any demand, allegations or claims against the Company, in the
                                         event the Company cannot make the necessary adjustment for reasons beyond the Company’s
                                         control.

 

		8.4.	Without
                                         derogating from the provisions of the Compensation Policy, to the extent that any amount
                                         or fees paid to the Consultant hereunder shall be revealed, within three (3) years of
                                         the payment thereof, to have been paid based on erroneous calculations that have been
                                         restated in the Company's financial statements, the Consultant shall repay the Company
                                         amount paid in excess as aforesaid; all in accordance with the provisions of the Compensation
                                         Policy.

 

    	 	8	 

     

    

 

	9.	Securities
                                         Internal Compliance Plan; Insider Trading Policy

 

Consultant
declares and confirms, that he is familiar and aware that the Company has adopted a Securities Internal Compliance Plan (the "Internal
Compliance Plan"), and are familiar with its terms, obligations and restrictions, and shall act in accordance with the
provisions and guidelines of the Internal Compliance Plan in force, and as shall be determined from time to time.

 

	10.	Term
                                         and Termination

 

		10.1.	This
                                         Agreement shall be in effect as of the Effective Date and shall continue in full force
                                         and effect for an undefined period, until terminated as hereinafter provided (the "Term").

 

		10.2.	At
                                         any time commencing as of the Effective Date, each party shall have the right to terminate
                                         this Agreement, with or without cause, by providing a 30-day advance written notice to
                                         the other party (the " Notice Period"), during which Consultant shall
                                         be obligated to continue to provide the Services to the Company, unless instructed otherwise
                                         by the Company and in such event he shall be entitled to the compensation due to him
                                         until the original end date. During the Notice Period, the Consultant shall be entitled
                                         to all Compensations detailed in Section ‎3 above, to the extent applicable.

 

Upon
such time that Consultant ceases to provide the Services hereunder, it shall immediately return to Company any and all equipment
provided to the Consultant pursuant to this Agreement, if any.

 

		10.3.	Notwithstanding
                                         anything to the contrary herein, the Company may terminate this Agreement at any time,
                                         effective immediately, without need for prior written notice, and without derogating
                                         from any other remedy to which the Company may be entitled, for Cause. For the purposes
                                         of this Agreement, the term "Cause" shall mean, but shall not be limited
                                         to: (i) a material breach by Consultant of any term of this Agreement; (ii) any breach
                                         by Consultant of its fiduciary duties to the Company, including, without limitation,
                                         any material conflict of interest for the promotion of Consultant’s benefit; (iii)
                                         Consultant fraud, felonious conduct or dishonesty; (iv) Consultant’s embezzlement
                                         of funds of the Company; (v) any conduct by Consultant which is materially injurious
                                         to the Company, monetary or otherwise; (vi) Consultant’s conviction of any felony;
                                         (vii) Consultant’s misconduct, gross negligence or willful misconduct in performance
                                         of his duties and/or responsibilities hereunder; or (viii) Consultant’s refusal
                                         to perform its duties and/or responsibilities hereunder for any reason other than illness
                                         or incapacity of Consultant, or Consultant’s disregard or insubordination of any
                                         lawful resolution and/or instruction of the Board with respect to Consultant’s
                                         duties and/or responsibilities towards the Company.

 

		10.4.	Upon
                                         termination of this Agreement, the Consultant shall cooperate with the Company and use
                                         its best efforts to assist the integration into the Company’s organization of the
                                         person or persons who will assume the Consultant’s responsibilities. At the option
                                         of the Company, the Consultant shall, during such period, either continue with its duties
                                         or remain absent from the premises of the Company, subject to applicable law.

 

    	 	9	 

     

    

 

	11.	Survival

 

The
provisions of Sections 3.3, ‎4 through 8 and ‎13.5 shall survive the termination of this Agreement for any reason whatsoever.

 

	12.	Notices
                                         

 

		12.1.	Any
                                         and all notices and communications in connection with this Agreement shall be in writing,
                                         addressed to the parties as follows:

 

	 	If
    to the Company:	Therapix
        Biosciences Ltd.

        

        Azrieli
        Center, 27th floor,

        Tel-Aviv
67025, Israel

	 	 	 
	 	If
    to Consultant:	

        

         

	 	 	 

		12.2.	All
                                         notices shall be given by registered mail (postage prepaid), by facsimile or email or
                                         otherwise delivered by hand or by messenger to the Parties’ respective addresses
                                         as above or such other address as may be designated by notice. Any notice sent in accordance
                                         with this Section ‎12 shall be deemed received upon the earlier of: (i) if sent by
                                         facsimile or email, upon transmission and electronic or other confirmation of receipt
                                         or (if transmitted and received on a non-business day) on the first business day following
                                         transmission and electronic or other confirmation of receipt, (ii) if sent by registered
                                         mail, upon 5 (five) days of mailing, and (iii) if sent by messenger, upon delivery.

 

	13.	Miscellaneous.

 

		13.1.	The
                                         execution, delivery and performance of this Agreement is subject to the obtainment of
                                         all applicable corporate and regulatory approvals, if and to the extent necessary.

 

		13.2.	Headings;
                                         Interpretation. Section headings contained herein are for reference and convenience
                                         purposes only and shall not in any way be used for the interpretation of this Agreement.

 

		13.3.	Entire
                                         Agreement. This Agreement constitutes the entire agreement between the Parties with
                                         respect to the subject matters hereof and supersedes all prior agreements, understandings
                                         and arrangements, oral or written, between the Parties with respect to the subject matters
                                         hereof.

 

		13.4.	Amendment;
                                         Waiver. No provision of this Agreement may be modified, waived or discharged unless
                                         such waiver, modification or discharge is agreed to in writing and signed by all Parties.
                                         No waiver by either Party at any time to act with respect to any breach or default by
                                         the other Party of, or compliance with, any condition or provision of this Agreement
                                         to be performed by such other Party shall be deemed a waiver of similar or dissimilar
                                         provisions or conditions at the same or at any prior or subsequent time.

 

    	 	10	 

     

    

 

		13.5.	Governing
                                         Law; Jurisdiction. This Agreement shall be governed by and construed and enforced
                                         in accordance with the laws of the State of Israel, without giving effect to the rules
                                         with respect to conflicts-of-law. Any dispute arising out of, or relating to this Agreement,
                                         its interpretation or performance hereunder shall be resolved exclusively by the competent
                                         court of the Central district, and each of the Parties hereby submits exclusively and
                                         irrevocably to the jurisdiction of such court.

 

		13.6.	Severability.
                                         The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability
                                         of any provision shall not affect the validity or enforceability of the other provisions
                                         hereof. If any part of this Agreement is determined to be invalid, illegal or unenforceable,
                                         such determined shall not affect the validity, legality or enforceability of any other
                                         part of this Agreement; and the remaining parts shall be enforced as if such invalid,
                                         illegal, or unenforceable part were not contained herein, provided, however,
                                         that in such event this Agreement shall be interpreted so as to give effect, to the greatest
                                         extent consistent with and permitted by applicable law, to the meaning and intention
                                         of the excluded provision as determined by such court of competent jurisdiction.

 

		13.7.	Successors
                                         and Assign; Assignment. This Agreement shall be binding upon and shall inure to the
                                         benefit of the Company, its successors and assigns. Neither this Agreement or any of
                                         the Consultant’s rights, privileges, or obligations set forth in, arising under,
                                         or created by this Agreement may be assigned or transferred by the Consultant without
                                         the prior consent in writing of the Company, except by will or by the laws of descent
                                         and distribution

 

[the
remainder of this PAGE was intentionally left blank]

 

    	 	11	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Consulting Agreement as of the date first above-mentioned.

 

     

	/s/ Therapix Biosciences Ltd.	 	/s/ Doron Ben - Ami
	Therapix
Biosciences Ltd. 	 	Doron
Ben-Ami

 

	By:	 	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}]]